Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2397-768X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies ; volume:6 ; number:1 ; day:23 ; month:10 ; year:2022 ; pages:1-17 ; date:12.2022
npj precision oncology ; 6, Heft 1 (23.10.2022), 1-17, 12.2022
- Urheber
-
Lidsky, Michael E.
Wang, Zechen
Lu, Min
Liu, Annie
Hsu, S. David
McCall, Shannon J.
Sheng, Zhecheng
Granek, Joshua A.
Owzar, Kouros
Anderson, Karen S.
Wood, Kris C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-022-00320-5
- URN
-
urn:nbn:de:101:1-2023010621124182820937
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lidsky, Michael E.
- Wang, Zechen
- Lu, Min
- Liu, Annie
- Hsu, S. David
- McCall, Shannon J.
- Sheng, Zhecheng
- Granek, Joshua A.
- Owzar, Kouros
- Anderson, Karen S.
- Wood, Kris C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transarterial Therapies for the Treatment of Intrahepatic Cholangiocarcinoma
Leveraging weak complementary labels enhances semantic segmentation of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma
The focus clinical research in intrahepatic cholangiocarcinoma
Prognostic factors in patients with intrahepatic cholangiocarcinoma
Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
Maffucci Syndrome with Intrahepatic Cholangiocarcinoma: A Case Report
Is Lymphadenectomy Reasonable for Elderly Intrahepatic Cholangiocarcinoma Patients?
Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary
Transarterial Therapies for the Treatment of Intrahepatic Cholangiocarcinoma
Leveraging weak complementary labels enhances semantic segmentation of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma
The focus clinical research in intrahepatic cholangiocarcinoma
Prognostic factors in patients with intrahepatic cholangiocarcinoma
Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
Maffucci Syndrome with Intrahepatic Cholangiocarcinoma: A Case Report
Is Lymphadenectomy Reasonable for Elderly Intrahepatic Cholangiocarcinoma Patients?
Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary
Transarterial Therapies for the Treatment of Intrahepatic Cholangiocarcinoma
Leveraging weak complementary labels enhances semantic segmentation of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma
The focus clinical research in intrahepatic cholangiocarcinoma
Prognostic factors in patients with intrahepatic cholangiocarcinoma
Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
Precision oncology for intrahepatic cholangiocarcinoma in clinical practice
Maffucci Syndrome with Intrahepatic Cholangiocarcinoma: A Case Report
Is Lymphadenectomy Reasonable for Elderly Intrahepatic Cholangiocarcinoma Patients?